相关临床试验
45
17 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1949
进行中（未招募）
16
35.6%
已完成
23
51.1%
尚未招募
1
2.2%
招募中
3
6.7%
终止
1
2.2%
撤回
1
2.2%
暂无批准数据
- A 25-year study of 22,534 UK adults found men with cardiovascular disease had a 17.3% lifetime cancer risk, compared with 12.8% for women with CVD. - Smoking, obesity and excessive alcohol consumption were identified as the primary drivers, with the strongest links seen in lung and oesophageal cancers. - Men with CVD also faced elevated mortality from gastric, oesophageal and lung cancers, prompting calls for improved risk management and targeted screening. - Researchers urged new care pathways to identify and prevent cancer in patients with cardiac conditions, reversing the current cardio-oncology focus.
- Phase III FAST-Forward trial demonstrates that a 1-week radiotherapy course (26-27 Gy in 5 treatments) provides equivalent cancer control to the standard 3-week regimen (40 Gy in 15 treatments) after 10 years of follow-up. - The shorter treatment protocol maintains comparable safety profiles without additional long-term adverse effects, potentially improving patient convenience and reducing hospital visits. - Researchers highlight that the streamlined approach could expand radiotherapy access globally, particularly benefiting patients with limited hospital access and healthcare systems in lower-income countries.
- New research shows smoking more than doubles the risk of cryptogenic strokes in adults under 50, with heavy smokers facing over four times the risk compared to non-smokers. - Male smokers have three times higher stroke risk than non-smokers, with those consuming more than a pack daily for 20 years facing nearly seven times the risk. - The findings highlight smoking as a key factor in the increasing incidence of unexplained strokes among younger adults, emphasizing the importance of smoking prevention efforts.
